Category: CannabisNewsWire Release

CannabisNewsBreaks – Canopy Rivers Inc.’s (TSX.V: RIV) (OTC: CNPOF) Headset Launches Cannabis Market Intelligence Tool in Canada

Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) this morning announced that its portfolio company, Headset, Inc., has launched its competitive cannabis market intelligence tool in Canada. Headset Insights is already trusted by hundreds of operators in numerous U.S. markets and provides users with real-time market data to help uncover strategic opportunities, monitor consumer trends and behaviors, and keep tabs on competitors. “This announcement from Headset is a testament to the company’s rapid growth since being backed by RIV and joining our ecosystem in January 2019,” Canopy Rivers President and CEO Narbe Alexandrian said in the news release. “We believe that Headset Insights is an unmatched resource for retailers, including Canopy Rivers portfolio company YSS, empowering them to make data-driven decisions based on trends unique to the Canadian market.”

To view the full press release, visit http://cnw.fm/cgW3S

About Canopy Rivers Inc.

Canopy Rivers is a unique investment and operating platform structured to pursue investment opportunities in the emerging global cannabis sector. Canopy Rivers works collaboratively with Canopy Growth Corporation (TSX: WEED, NYSE: CGC) to identify strategic counterparties seeking financial and/or operating support. Canopy Rivers has developed an investment ecosystem of complementary cannabis operating companies that represent various segments of the value chain across the emerging cannabis sector. As the portfolio continues to develop, constituents will be provided with opportunities to work with Canopy Growth and collaborate among themselves, which Canopy Rivers believes will maximize value for its shareholders and foster an environment of innovation, synergy and value creation for the entire ecosystem. For more information, visit the company’s website at www.CanopyRivers.com.

NOTE TO INVESTORS: The latest news and updates relating to CNPOF are available in the company’s newsroom at  http://cnw.fm/RIV

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

420 with CNW – Missouri Receives More than 2,100 Medical Marijuana Business Applications

The Department of Health in Missouri announced earlier this week that it had received 2,163 applications from companies that wanted to operate medical cannabis facilities in the state. This tally reflects the applications that were received by the time the 4:30 pm Monday deadline clocked.

Only a small fraction of those applicants will be given licenses by the end of this year since the number of dispensary licensees required is 192 while 86 licenses will be given to manufacturing facilities. 60 licenses are earmarked for medical marijuana cultivators while ten are for testing facilities. This means that the state will issue a total of 348 licenses.

Missouri was one of the states in which voters approved a ballot initiative to legalize medical cannabis during the midterm elections. When regulators announced that interested companies should start submitting their applications, the response was massive.

When the constitutional amendment was passed, the state was required to start receiving facility license applications by August 3. The original deadline for the submission of license applications was August 17 but the huge demand made the Health Department to extend that deadline to Monday (Aug. 19).

The extension was also motivated by the desire to give all those people who had paid the non-refundable license application fee a chance to submit their applications for consideration when the applications are being assessed.

The constitutional amendment also required the regulators to begin accepting applications from patients and caregivers by June 4. By the start of this week, 6,500 patients and caregivers had expressed interest in participating in the medical marijuana program.

Dr. Randall Williams, the Missouri Health Department director, revealed that the regulators were pleased by the enthusiasm exhibited for the medical cannabis program. He explained that everything that his department is doing is geared at providing excellent customer service, and that was partially why they had extended the deadline for the submission of facility applications.

Now that the license application deadline has passed, the next stage will involve scoring the applications in order to identify which ones will be selected. The scoring will be undertaken by Wise Health Solutions, a third-party private company based in Nevada.

By the end of this year, Missouri will name the successful applicants and work will begin in earnest so that by mid-2020, patients can start accessing medical cannabis products in licensed dispensaries.

Experts applaud the seamless way in which Missouri has handled the process so far and they expect industry actors like Youngevity International Inc. (NASDAQ: YGYI) and Cannabis Strategic Ventures Inc. (OTCQB: NUGS) to also be pleased that everything is on track as laid out in the constitutional amendment which legalized medical marijuana.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Federally Funded Journal Reveals How Prohibition is Endangering Marijuana Consumers

It is ironical that federal dollars were used to publish a journal report which blames the federal prohibition of marijuana for putting cannabis consumers at risk since there is no federal guidance on the safety standards that the industry should adhere to.

Environmental Health Perspectives, an open access journal whose work is supported by funding from the National Institutes of Health, published this damning report in its edition for this week.

The report observes that because marijuana is still considered an illegal drug by the federal government, regulatory agencies like the FDA and the EPA cannot provide guidance to the industry on how matters of consumer safety can be addressed.

Consequently, each state that has legalized marijuana in some form has been left to its own devices regarding how to protect the millions of marijuana users.

Concerns about heavy metals, the use of butane during the extraction of concentrates and the presence of microbial contaminants are issues that federal regulators like the EPA and FDA would look into if marijuana was legal federally.

A clear example of how this oversight would work was exemplified last week when the Environmental Protection Agency (EPA) announced that it would soon call for public comment as part of its process of considering applications for pesticides that can be used in hemp fields. Hemp was legalized last year, and that explains why the EPA is stepping in to provide guidance regarding the crop protection products which can be used during the cultivation of industrial hemp.

Because marijuana is still illegal federally, there is no consistency in the implementation of consumer protection since each state has its own laws on the matter.

The journal quotes Ben Gelt, the board chairman of the Cannabis Certification Council, as saying that consumers in non-legal states face the greatest safety risks since there is no regulation at all of the marijuana sold there illegally.

Gelt adds that not a single state that has legalized marijuana has got everything right in terms of the consumer protection measures embedded in the state laws. There is need for a lot of research so that all the gaps can be filled, Gelt stated.

The journal has a disclaimer stating that while it received financial support from the National Institutes of Health and other organizations, such support should not be construed to mean that those entities endorse or condone the views, products, services and any other information contained in the publication.

All the same, experts agree that industry actors like Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) and Willow Biosciences Inc. (CSE: WLLW) must be chuckling at the irony of federal money calling out the federal government for not legalizing marijuana.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CBDNewsBreaks – Neutra Corp. (NTRR) Establishing Foothold in Mounting Hemp-Based Product, CBD Markets

Neutra (OTCQB: NTRR), an early-stage research and development company, is diligently working to establish its position within the increasing hemp-based product and CBD markets. A recent article discussing the company reads, “Neutra is working to establish its position in the particularly lucrative CBD market. According to industry forecasts, hemp-based product sales could reach $22 billion by 2022. Several factors contribute to the growth, including rapid legalization, higher levels of consumer awareness and significantly more research being conducted into the health benefits of CBD. . . . The range of CBD products is constantly growing. Currently, it includes oils, creams, supplements, analgesics, beverages, edibles and various others. CBD can also be inhaled to deliver anti-depression benefits, anti-inflammatory effects, pain relief and relief from the symptoms of neurodegenerative disorders like Alzheimer’s and Parkinson’s disease. Unlike other compounds, CBD does not cause addiction. It also avoids the typical high that stems from THC use.”

To view the full article, visit http://cnw.fm/s9Xi5

About Neutra Corp.

Neutra Corp. is an early-stage research and development company commited to bringing modern, healthy-living solutions to a multibillion-dollar market. Cutting-edge technologies within the nutraceuticals, food and drug, and environmental purification sectors are creating a new kind of world culture — one where consumers are demanding access to products that promote health and stave off potential health dangers. One of the nutraceutical submarkets is the new, thriving, hemp-based CBD market, in which the company intends to participate. For more information, visit the company’s website at www.Neutrainc.com.

NOTE TO INVESTORS: The latest news and updates relating to NTRR are available in the company’s newsroom at http://cnw.fm/NTRR

About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask Our Editor

CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com

CannabisNewsBreaks – City View Green Holdings Inc. (CSE: CVGR) Creating Seed-to-Retail Cannabis Network

City View Green Holdings (CSE: CVGR) is a vertically integrated cannabis company with a primary focus on the development of a seed-to-retail cannabis network. Recently, the company finalized an agreement securing a 40,000-square-foot cultivation facility that CVGR plans to use to produce a pharmaceutical-grade crop. An article discussing the company reads, “City View Green recently announced that it had completed a previously detailed goal of transferring its option to purchase the facility in Brantford, Ontario, just southwest of Toronto, to an arms-length financier who has also completed a five-year renewable lease agreement with CVGR that includes a first right of refusal on any potential future sale of the property. . . . The financier will provide all the required buildout and capital improvements necessary for the mandatory Health Canada licenses and to make the facility a fully operational cannabis cultivation and extraction site, according to the announcement (http://cnw.fm/dxFn9). The new landlord obtained one million common share purchase warrants in exchange, each of which can be used to purchase one common share of the company at a price of $0.18 during the next five years.”

To view the full article, visit http://cnw.fm/3P3Eq

About City View Green Holdings Inc.

City View Green has been structured to be a vertically integrated cannabis company focused on seed to retail. Upon receipt of its Cannabis Act license, City View Green will incorporate growing, extraction, production and retail at its Brantford, Ontario, facility. It is the company’s intention that City View Green will grow exceptional-quality cannabis and produce high-quality extracts. City View Green expects to produce high-quality edible products, distillates and water-soluble products — once these products are legalized — for the beverage market. In addition, City View Green owns a 19.9% stake in Budd Hutt Inc., a retail-focused cannabis company with access to licenses in Alberta and other retail opportunities across Canada. The company expects that Budd Hutt Inc. will secure shelf space and distribution opportunities for City View Green’s products. City View’s future is green. Follow the green. For more information, visit the company’s website at www.CityViewGreen.ca.

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

CBDNewsBreaks – Geyser Brands Inc. (TSX.V: GYSR) Subsidiary Attains License, Enables Health Care Brands to Add CBD

Global science-led consumer health-care company Geyser Brands’ (TSX.V: GYSR) wholly owned subsidiary, Apothecary Botanicals, has received a standard processing license from Health Canada. A recent article discussing the company reads, “‘The license allows us to add value to existing consumer health care brands by providing them the platform to add CBD,’ Geyser CEO Andreas Thatcher stated in a news release (http://cnw.fm/8FyOi). ‘It also reflects our business model to focus our licensed producer on delivering scale through manufacturing and distribution for brand companies.’ . . . The new license allows Geyser to begin work to extend its cannabidiol products to the regulated Canadian consumer medical market as the company awaits its R&D and sales licenses. Physical modifications to the Apothecary Botanicals manufacturing facility to deliver GMP-compliant capacity are complete, with production of in-house formulated branded products expected to begin sometime in late summer.”

To view the full article, visit http://cnw.fm/dO6oL

About Geyser Brands Inc.

Geyser Brands builds health-based, hemp-CBD consumer products in the nutraceutical, cosmetics, food-and-beverage and pet sectors worldwide. R&D investment in NanoFusion, a proprietary all-natural nanotechnology, delivers topical, cream, beverages and baked goods, oil, and tincture formulations with superior bioavailability and water solubility. Geyser Brands is a Health Canada-approved licensed producer (“LP”) in Port Coquitlam, British Columbia, that holds a cultivation license and is anticipating its processing and sales licenses. The company is exclusively focusing on leveraging these assets to provide the regulatory infrastructure for its global brands and distribution strategy, as well as acquiring hemp- and plant-based brands and infusing them with new CBD product lines in jurisdictions where the therapeutic ingredient is legal. The company’s proprietary NanoFusion technology surrounds oils and solves for the insolubility of CBD. Geyser Brands will utilize its 7,000-square-foot licensed facility in British Columbia for the manufacturing and international distribution of its hemp- and CBD-based products. For more information, visit the company’s website at www.GeyserBrands.com.

NOTE TO INVESTORS: The latest news and updates relating to GYSR are available in the company’s newsroom at http://cnw.fm/GYSR

About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask Our Editor

CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com

CannabisNewsBreaks – MustGrow Biologics Corp. (CSE: MGRO) Developing Natural Biopesticide Products to Ensure Compliant, Pest-Free Cannabis Production

Agricultural biotech company MustGrow Biologics (CSE: MGRO) is engaged in the development and commercialization of a portfolio of natural biopesticides and biofertilizer products for the cannabis industry. A recent article discussing the company reads, “Canada’s licensed producers (‘LPs’) are required by law to demonstrate that no unauthorized pesticides were used on their products or contaminated them (http://cnw.fm/QFu7L), and mandatory testing is underway to ensure that LPs comply. Failure of Health Canada’s sampling and testing program for unauthorized pest control products could result in product seizure or destruction, recall of products sold, suspension or revocation of the firm’s license, or a monetary penalty of up to C$1 million, according to Health Canada. . . . Through MustGrow’s eventual suite of biostimulant/biofertilizer offerings, Canadian cannabis license holders may have access to products that aid in the production of compliant, pest-free cannabis. MustGrow’s science-based suite of signature products have already demonstrated control of many soil-borne diseases and pests that affect cannabis production, including Botrytis (grey mold), Pythium root rot, Rhizoctonia fungus, Fusarium, nematodes, Verticillium wilt, Phytophthora root rot and Sclerotinia. MustGrow’s products are recognized as safe and are EPA- and PRMA-approved for use on fruits and vegetables.”

To view the full article, visit http://cnw.fm/RQg08

About MustGrow Biologics Corp.

MustGrow is an agricultural biotech company focused on developing and commercializing its patented natural biologic product that acts as a pesticide, fungicide nematicide and fertilizer. Targeting the fruit, vegetable, turf, ornamentals and cannabis industries, MustGrow has designed a U.S. EPA-approved organic solution that uses the mustard seed’s natural defense mechanisms to protect plants from pests and diseases. Approximately $9 million has been spent on 110 independent tests, validating MustGrow’s remarkably safe and effective granular product. MustGrow’s granular product is EPA-approved across all key U.S. states as a fertilizer and pesticide (currently limited to fertilizer in California) and is designated by Health Canada’s Pest Management Regulatory Agency as a fruit, vegetable, turf and ornamental biopesticide and biofertilizer. In the cannabis space, MustGrow is currently developing reliable, safe and biological solutions that adhere to Health Canada’s strict regulations. MustGrow is positioning its signature product as an effective preplant soil treatment, reducing the chance for any added soil to a greenhouse to bring in pests or diseases. MustGrow expects its biopesticide and biofertilizer will help licensed cannabis producers control the same conditions addressed in fruit and vegetable crops. For more information, visit the company’s website at www.MustGrow.ca.

NOTE TO INVESTORS: The latest news and updates relating to MGRO are available in the company’s newsroom at http://cnw.fm/MGRO

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

CBDNewsBreaks – SinglePoint, Inc. (SING) President Discusses CBD Cigarette Product on MoneyTV with Donald Baillargeon

Technology and investment company SinglePoint (OTCQB: SING) was featured on this week’s episode of MoneyTV with Donald Baillargeon. The internationally syndicated program covers money-focused topics, featuring various companies and in-depth CEO and executive interviews that offer insights into operations and future outlooks. MoneyTV is viewed in over 200 million households in more than 75 countries. On this week’s program, SinglePoint president Will Ralston discussed the company’s PURE CBD cigarette product that uses 100% American grown hemp. “We’ve gotten a lot of great feedback over the last week,” SinglePoint president Will Ralston stated in the interview. “We’re very excited about the market size for this particular product.”

To view the full interview, visit http://cnw.fm/Ty7GH

To view the full press release, visit http://cnw.fm/hXPu7

About SinglePoint Inc.

SinglePoint is a technology and investment company with a focus on acquiring companies that will benefit from the injection of growth capital and technology integration. The company portfolio includes mobile payments, ancillary cannabis services and blockchain solutions. Through acquisitions into horizontal markets, SinglePoint is building its portfolio by acquiring an interest in undervalued companies, thereby providing a rich, diversified holding base. Through SingleSeed, the company is providing products and services to the cannabis industry. For more information, visit the company’s website at www.SinglePoint.com.

NOTE TO INVESTORS: The latest news and updates relating to SING are available in the company’s newsroom at http://cnw.fm/SING

About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask Our Editor

CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com

420 with CNW – Thai State Hospitals Start Distributing Marijuana Oils

Thai state hospitals have stocked up on cannabis oils and are ready to start dispensing them to patients, according to a press release by Anutin Chanvirakul, the Public Health Minister who also doubles as the Deputy Prime Minister of Thailand.

Chanvirakul revealed that Thai state hospitals received a total of 4,500 bottles of marijuana extracts starting on August 7 as a result of the law which was passed in December to make medical cannabis legal in the Asian country.

Under this new law, the government will be responsible for regulating the production, processing and sale of medical marijuana products. Companies will have to apply and be granted licenses before they engage in any activity connected to this new medical marijuana industry.

The Government Pharmaceutical Organization (GPO), an agency run by the Thai government, will work with other state agencies to avail a total of 200,000 bottles of marijuana oil on a monthly basis starting in the month of September. To meet this requirement, the GPO intends to start growing marijuana in greenhouses next year so that supply shortages don’t jeopardize the implementation of the medical marijuana program.

The marijuana oils being stockpiled in state-run hospitals will be given out free of charge to the qualifying patients who are enrolled in the state’s universal health care scheme (the Gold Card) or any of the other health insurance schemes available in the country.

Thai doctors will first diagnose each patient and then recommend the particular cannabis oil formulation that is best suited to help that patient. Based on this prescription, the hospital pharmacy will dispense the oil to be used by the patient.

The addition of medical marijuana to Thai law is widely seen as a boost to the agricultural sector of the country since its favorable conditions can position Thailand as a leader in marijuana production in the region and internationally.

Prohibition Partners, a marijuana research company, estimates that the marijuana industry in Thailand could be worth at least $661 million by 2024.

However, this potential can only be turned into reality when marijuana cultivation and processing is ramped up quickly enough to meet the expected high demand among patients in the country with a 300-year history of using marijuana as a medicine before the drug was outlawed in the 1930s.

The country hopes to develop its own cannabis strains that will compete favorably on the world marijuana market. Laos, Malaysia and the Philippines are currently considering to legalize marijuana for medicinal purposes.

Experts welcome the bold step taken by this Asian country to embrace medical marijuana and they believe that industry participants like VIVO Cannabis Inc. (TSX.V: VIVO) (OTCQX: VVCIF) and VPR Brands LP (OTCQB: VPRB) may be thrilled that the Asian medical marijuana market could soon open up.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Study Finds Cannabis Flower Tops Other Cannabis Products in Providing Pain Relief

A study whose findings were published towards the end of July has found that dried marijuana flower provides the highest level of pain relief when compared to other marijuana products. This conclusion was made after analyzing the data collected by an app which allows medical marijuana users to track the effects of the different medical marijuana products and dosage for different health conditions.

The New Mexico University researchers wrote that higher THC concentrations in marijuana flower and other cannabis products were associated with better pain relief outcomes among the patients who used the Releaf App to track their medical cannabis usage.

In contrast, CBD showed pain relief effects only up to a certain level, while the additional concentration was associated with no additional benefit yet gastrointestinal complaints increased among the patients who used products with higher concentrations of CBD. This is in line with research that shows the benefits of CBD start leveling off when patients consume higher doses of the compound.

Overall, the study looked at 20,513 sessions of marijuana use logged in the app by 2,987 patients for more than two years (June 6, 2016 to October 24, 2018). 95 percent of all the patients reported marked relief from pain and the average reduction was 3.1 points on a self-reported pain scale ranging from 0-10. The starting level of pain was an average of 5.87 and this average dropped to 2.77 after the patients had used marijuana for their pain.

Another highlight of this study was that cannabis concentrates were linked to more side effects than dried cannabis flower. The researchers suspect that those negative side effects could have been caused by the residues of the solvents used to extract the concentrates, or because other cannabis compounds, such as terpenes and flavonoids, are lost during the extraction process.

The research also revealed that marijuana products which were hybrids of sativa and indica marijuana strains exhibited better pain management when compared to those that were either purely indica or purely sativa in nature.

It was also noted that the patients who said that they had pain in the stomach or gastrointestinal system benefited most from products with lower concentrations of THC than from products high in THC.

Interestingly, the patients who used marijuana tinctures, pills and edibles reported less relief from pain when compared to those who used cannabis concentrates, dried flower and topical products.

This research done on a large population of medical marijuana users provides some of the best proof so far available regarding the role of THC in pain management. Industry watchers are eager to see how different entities like Therma Bright Inc. (TSX.V: THRM) (OTC: THRBF) and TransCanna Holdings Inc. (CSE: TCAN) (FRA: TH8) will make use of these research findings in their products.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com